Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innovation Pharmaceuticals Inc IPIX

Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is... see more

GREY:IPIX - Post Discussion

View:
Post by kaos12 on Mar 04, 2019 11:43pm

Good heavens!

Maybe today will get us some attention. Up 26%.  We’re expecting a deal folks, isn’t anyone paying attention?  Hopefully some of those who lost money in the past will have a second look. Many disappointments with Prurisol but Brilacidin could lead the way. Setting up in Ireland. Think about the tax effect. IMHO I think Leo is starting to put all the pieces together. Still, if I ever met the man personally I would call him a greedy a hole for his wages with a low penny stock. $450,000 US/ year is unbridled greed in my books. Hopefully he is about to make a few of us a few Benjamin’s.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities